Does OLMESARTAN MEDOXOMIL Cause Hyperkalaemia? 160 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 160 reports of Hyperkalaemia have been filed in association with OLMESARTAN MEDOXOMIL (OLMESARTAN MEDOXOMIL). This represents 1.3% of all adverse event reports for OLMESARTAN MEDOXOMIL.
160
Reports of Hyperkalaemia with OLMESARTAN MEDOXOMIL
1.3%
of all OLMESARTAN MEDOXOMIL reports
6
Deaths
129
Hospitalizations
How Dangerous Is Hyperkalaemia From OLMESARTAN MEDOXOMIL?
Of the 160 reports, 6 (3.8%) resulted in death, 129 (80.6%) required hospitalization, and 30 (18.8%) were considered life-threatening.
Is Hyperkalaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OLMESARTAN MEDOXOMIL. However, 160 reports have been filed with the FAERS database.
What Other Side Effects Does OLMESARTAN MEDOXOMIL Cause?
Sprue-like enteropathy (3,482)
Gastrooesophageal reflux disease (1,819)
Acute kidney injury (1,587)
Weight decreased (1,569)
Haemorrhoids (1,316)
Diarrhoea (1,300)
Hiatus hernia (938)
Dizziness (885)
Large intestine polyp (839)
Constipation (796)
What Other Drugs Cause Hyperkalaemia?
METFORMIN (2,565)
SPIRONOLACTONE (2,518)
FUROSEMIDE (2,035)
RAMIPRIL (1,383)
SACUBITRIL\VALSARTAN (1,192)
SULFAMETHOXAZOLE\TRIMETHOPRIM (1,036)
LISINOPRIL (948)
POTASSIUM (944)
BISOPROLOL (850)
TACROLIMUS (713)
Which OLMESARTAN MEDOXOMIL Alternatives Have Lower Hyperkalaemia Risk?
OLMESARTAN MEDOXOMIL vs OLMETEC
OLMESARTAN MEDOXOMIL vs OLODATEROL
OLMESARTAN MEDOXOMIL vs OLODATEROL\TIOTROPIUM
OLMESARTAN MEDOXOMIL vs OLOPATADINE
OLMESARTAN MEDOXOMIL vs OLUTASIDENIB